LTK | Leukocyte receptor tyrosine kinase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
LYN | LYN proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
MATK | Megakaryocyte-associated tyrosine kinase | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
MERTK | MER proto-oncogene, tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MET | MET proto-oncogene, receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
MST1R | Macrophage stimulating 1 receptor (c-met-related tyrosine kinase) | CD markers Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NTRK1 | Neurotrophic tyrosine kinase, receptor, type 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
NTRK2 | Neurotrophic tyrosine kinase, receptor, type 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
NTRK3 | Neurotrophic tyrosine kinase, receptor, type 3 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PDGFRA | Platelet-derived growth factor receptor, alpha polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PDGFRB | Platelet-derived growth factor receptor, beta polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
PTK2 | Protein tyrosine kinase 2 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PTK2B | Protein tyrosine kinase 2 beta | Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PTK6 | Protein tyrosine kinase 6 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
PTK7 | Protein tyrosine kinase 7 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
RET | Ret proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ROR1 | Receptor tyrosine kinase-like orphan receptor 1 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ROR2 | Receptor tyrosine kinase-like orphan receptor 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
ROS1 | ROS proto-oncogene 1 , receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
SRC | SRC proto-oncogene, non-receptor tyrosine kinase | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
SRMS | Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
STYK1 | Serine/threonine/tyrosine kinase 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
SYK | Spleen tyrosine kinase | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Mixed |
TEC | Tec protein tyrosine kinase | Cytoskeleton related proteins Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
TEK | TEK tyrosine kinase, endothelial | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
TNK1 | Tyrosine kinase, non-receptor, 1 | Enzymes Predicted intracellular proteins
| | | | | Mixed |
TNK2 | Tyrosine kinase, non-receptor, 2 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
TXK | TXK tyrosine kinase | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
TYK2 | Tyrosine kinase 2 | Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
TYRO3 | TYRO3 protein tyrosine kinase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
YES1 | YES proto-oncogene 1, Src family tyrosine kinase | Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ZAP70 | Zeta-chain (TCR) associated protein kinase 70kDa | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |